T Cell Balance Gene Expression Regulatory Network Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The molecular circuits controlling T cell balance, including Th17 cell differentiation and function, remain poorly understood, and existing methods are inadequate for primary T cells, necessitating a better understanding of the dynamic regulatory network for therapeutic and diagnostic applications.
Innovation Solution
The development of methods and compositions to detect and modulate T cell balance by targeting specific genes and gene products such as Toso, Ctla2b, Gatm, and others, using agents like antibodies or small molecules to influence Th17 cell differentiation and function, allowing for personalized treatment approaches.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If perturbation-based approaches are used to reconstruct regulatory networks, then short-term responses can be studied, but the methods cannot be readily applied to primary T cells
Solution Approach 1:
The patent uses computational algorithms as intermediaries to analyze gene expression data from primary T cells without requiring direct perturbation of the cells. The algorithms process transcriptomic data to reconstruct regulatory networks, allowing study of primary T cells through indirect computational analysis rather than direct experimental manipulation.
Solution Approach 2:
The patent replaces mechanical perturbation-based experimental approaches with computational analysis methods. Instead of physically manipulating primary T cells to reconstruct regulatory networks, the invention uses bioinformatics algorithms to infer regulatory relationships from gene expression data, substituting computational mechanics for experimental manipulation.
2Loss of information
If existing methods are used to study T cell balance, then some general insights can be gained, but the molecular circuits controlling Th17 cell differentiation and function remain poorly understood
Solution Approach 1:
The patent segments the analysis into specific Th17 cell-related gene modules and regulatory circuits rather than studying T cells as a whole. By focusing computational analysis on Th17-specific gene expression patterns and regulatory elements, the method provides detailed molecular circuit understanding while preserving general T cell balance insights.
Solution Approach 2:
The patent applies local quality by focusing computational analysis on specific Th17 cell differentiation pathways and molecular circuits rather than uniform analysis of all T cell processes. This targeted approach enhances understanding of Th17-specific molecular mechanisms while maintaining broader T cell context.
3Measurement precision
If comprehensive gene expression analysis is performed to understand T cell balance, then regulatory networks can be identified, but the complexity of analyzing multiple genes and their interactions increases
Solution Approach 1:
The patent extracts key regulatory genes and molecular circuits from comprehensive gene expression data through computational filtering and analysis. By identifying and focusing on the most relevant Th17-related genes and their interactions, the method reduces analysis complexity while maintaining precision in understanding T cell balance regulation.
Solution Approach 2:
The patent employs dynamic computational algorithms that adaptively analyze gene expression data, prioritizing genes and interactions most relevant to Th17 cell differentiation and function. This dynamic approach automatically adjusts analysis complexity based on data characteristics, reducing manual intervention while maintaining high measurement precision.
Data Source
AI summary
This invention relates generally to compositions and methods for identifying the regulatory network that modulates, controls or otherwise influences T cell balance, for example, Th17 cell differentiation, maintenance and/or function, as well compositions and methods for exploiting the regulatory network that modulates, controls or otherwise influences T cell balance in a variety of therapeutic and/or diagnostic indications. This invention also relates generally to identifying and exploiting target genes and/or target gene products that modulate, control or otherwise influence T cell balance in a variety of therapeutic and/or diagnostic indications.